Lung Cancer Clinical Trial
Official title:
A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors
Aim: To develop and testing a home exercise program for lung cancer survivors to improve
their exercise tolerance and quality of life during the rehabilitation phase.
Design: An experimental design will be used in the study. The 90 lung cancer survivors, who
were diagnosed with lung cancer within one year and have completed their initial cancer
treatment, will be recruited and randomized to the control or intervention group. After
pre-test, the intervention participants will receive a 60 minutes of teaching regarding the
home rehabilitation exercise program, with a printed exercise manual. The intervention
participant will also receive a weekly phone call from the interventionist to enhance their
exercise adherence and helping to overcome exercise barriers. The similar outcome measures as
study one will be assessed on the baseline, 1th month, 3th month, and 6th month.
Measurements: The study outcomes will be evaluated by three physical measures, six-minute
walk test, Modified Borg Scale, 30-second Chair Sit-to-Stand Test, and 30-second Chair
Sit-to-Stand Test, as well as a study questionnaire including Functional Assessment of Cancer
Therapy-Lung (FACT-L) and FACIT-Fatigue. For study one the following data will be collected
from the patient'schart: post-operative pulmonary complications, days of chest tube
insertion, and days of hospitalization.
Data analysis: Descriptive analysis will be used to describe patients'demongraphics, disease
variables, and outcome variables. The Chi-square, T-test, and General Linear Mix-effect Model
will be used to test the efficacy of the study interventions.
Background: With appropriate treatment, lung cancer patients can be a long-term survivor.
However, many patients suffered from post-operative pulmonary complications, limited activity
tolerance, and poor quality of life. Nurses in a great position to provide individualized
health education regarding exercise for these patients; therefore to develop and test
cost-effective nurses-lead lung rehabilitation exercise education programs deserver further
scientific efforts.
Aim: To develop and testing a home exercise program for lung cancer survivors to improve
their exercise tolerance and quality of life during the rehabilitation phase.
Design: An experimental design will be used in the study. The 90 lung cancer survivors, who
were diagnosed with lung cancer within one year and have completed their initial cancer
treatment, will be recruited and randomized to the control or intervention group. After
pre-test, the intervention participants will receive a 60 minutes of teaching regarding the
home rehabilitation exercise program, with a printed exercise manual. The intervention
participant will also receive a weekly phone call from the interventionist to enhance their
exercise adherence and helping to overcome exercise barriers. The similar outcome measures as
study one will be assessed on the baseline, 1th month, 3th month, and 6th month.
Measurements: The study outcomes will be evaluated by three physical measures, six-minute
walk test, Modified Borg Scale, 30-second Chair Sit-to-Stand Test, and 30-second Chair
Sit-to-Stand Test, as well as a study questionnaire including Functional Assessment of Cancer
Therapy-Lung (FACT-L) and FACIT-Fatigue. For study one the following data will be collected
from the patient'schart: post-operative pulmonary complications, days of chest tube
insertion, and days of hospitalization.
Data analysis: Descriptive analysis will be used to describe patients'demongraphics, disease
variables, and outcome variables. The Chi-square, T-test, and General Linear Mix-effect Model
will be used to test the efficacy of the study interventions.
Significance: The study results will provide evidence for the efficacy of pulmonary
rehabilitation and a home exercise program for enhancing exercise tolerance and quality of
life in lung cancer survivors.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05078918 -
Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors
|
N/A | |
Active, not recruiting |
NCT04548830 -
Safety of Lung Cryobiopsy in People With Cancer
|
Phase 2 | |
Completed |
NCT04633850 -
Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
|
||
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT05583916 -
Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery
|
N/A | |
Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
Not yet recruiting |
NCT06376253 -
A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers
|
Phase 1 | |
Recruiting |
NCT05898594 -
Lung Cancer Screening in High-risk Black Women
|
N/A | |
Active, not recruiting |
NCT05060432 -
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03667716 -
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
|
Phase 1 | |
Active, not recruiting |
NCT03575793 -
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
|
Phase 1/Phase 2 | |
Terminated |
NCT01624090 -
Mithramycin for Lung, Esophagus, and Other Chest Cancers
|
Phase 2 | |
Terminated |
NCT03275688 -
NanoSpectrometer Biomarker Discovery and Confirmation Study
|
||
Not yet recruiting |
NCT04931420 -
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
|
Phase 2 | |
Recruiting |
NCT06052449 -
Assessing Social Determinants of Health to Increase Cancer Screening
|
N/A | |
Recruiting |
NCT06010862 -
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
|
Phase 1 | |
Not yet recruiting |
NCT06017271 -
Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
|
||
Recruiting |
NCT05787522 -
Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
|
||
Recruiting |
NCT05087251 -
The Transitions Project: Efficacy Trial
|
N/A |